trial

Cognitive Remediation for Coordinated Specialty Care

NCTId NCT03930251
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Suspended
Enrollment 117 (actual)
Sponsored by New York State Psychiatric Institute, Washington Heights Community Service
Primary completion 2023-10-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Suspended
Enrollment
117 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2019-06-01
Primary completion
2023-10-31
Eligibility
ALL · 18 Years · 30 Years

Interventions & indications

Drugs
Clinic-Based Cognitive RemediationPartial-Remote Cognitive Remediation

Sponsors

New York State Psychiatric Institute, Washington Heights Community ServiceLead Sponsor
Columbia UniversityCollaborator
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Alice Medalia, PhDPrincipal Investigator

Sites

9 total
Brooklyn, United StatesBrooklyn, United StatesNew York, United StatesNew York, United StatesQueens, United StatesRochester, United StatesStaten Island, United StatesThe Bronx, United StatesThe Bronx, United States

Facts & assertions

4 sourced
Enrollment
117
Phase
NA
Primary Completion Date
2023-10-31
Status
SUSPENDED
relationships
The graph out of here
drug
Clinic-Based Cognitive Remediation
drug
Partial-Remote Cognitive Remediation
drug
lead_sponsor
New York State Psychiatric Institute, Washington Heights Community Service
company
collaborator
Columbia University
company
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication
investigator
Alice Medalia, PhD
person